Science Events in Seattle
Stay up-to-date with all of the life science events taking place in the Seattle area with the Science in Seattle events calendar! From academia to industry and biotech to pharma, our events calendar is your complete source for life science conferences, symposiums, networking, and workshops in Seattle. We even cover science pub nights and science fundraisers!
If you’re interested in promoting your life science event on the Science in Seattle events calendar, please use our event submission form.
- This event has passed.
STAT Digital Event Series: Combating Covid-19
April 22, 2020 - 10:00 am - 11:30 am
The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed.
Join STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments, who will come prepared to answer tough questions. They’ll discuss current findings, clinical trials, and efforts to expedite approvals as we face this global pandemic.
This series will take place on Zoom, an interactive platform where attendees will be able to not only see the discussions live, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website.
Schedule: Please note, dates and times are subject to change as the story evolves.
Part 1: Antibody drugs that target the coronavirus. April 8, 2020 at 1 PM EST
- Sponsor Introduction: Stephen J. Ubl, president and chief executive officer, PhRMA
- George Yancopoulos, co-founder, president and chief scientific officer, Regeneron
- Matt Herper, senior writer, medicine, and editorial director of events, STAT
You can watch the recorded conversation with George Yancopoulos here.
Part 2: Antiviral treatments — what are the odds? April 22, 2020 at 1PM EST
- Sponsor Introduction: Richard Moscicki, M.D., chief medical officer and executive vice president of Science and Regulatory Advocacy, PhRMA
- Diana Brainard, senior vice president, HIV and Emerging Viral Infections at Gilead Sciences, Inc.
- Matt Herper, senior writer, medicine, and editorial director of events, STAT
Part 3: Vaccines — can they come soon enough? May 6, 2020 at 1PM EST
- Sponsor Introduction: Clem Lewin, Ph.D., associate vice president of R&D strategy for vaccines, Sanofi
- Tal Zaks, chief medical officer, Moderna
- Matt Herper, senior writer, medicine, and editorial director of events, STAT
